https://www.avient.com/industries/healthcare/labware-diagnostics
Our polymer solutions and engineering materials include colorants for identification and differentiation, additives for added properties and functionalities, and thermoplastics that can withstand harsh chemicals and reagents.
https://www.avient.com/products/fiber-line-engineered-fiber-solutions/fiber-line-engineered-fiber-products/industrial-fabric-yarn
Achieve vibrant colors for safety, identification and aesthetics
https://www.avient.com/news/polyone-showcases-new-solutions-medical-training-models-mdm-west-2014
Percept™ Brand Protection Technology – Authentication technology to protect brand equity and defend against potential liability caused by non-authentic products; enables efficient field identification to thwart counterfieters
https://www.avient.com/news/polyone-launches-authentication-technologies-asia-chinaplas-2014
The Percept spectrum of technologies can be tailored to a wide variety of polymers, processing conditions, end-use applications, and range of authentication techniques based on overt, covert, or forensic-based identification solutions.
https://www.avient.com/technical-tips-transfer-printing
Keep all mill information from cartons or skid wrappers (lot, run and order numbers, dates, etc.) for proper identification, in case of a problem or claim.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Gabelli%2520%2526%2520Co%2520Specialty%2520Chemicals%2520Conference.pdf
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
Tax adjustments include the net tax expense/benefit from one-time income tax items, the set-up or reversal of uncertain tax position reserves and deferred income tax valuation allowance adjustments.
PolyOne �Investor Presentation Slide Number 2 Slide Number 3 Slide Number 4 Slide Number 5 Slide Number 6 Slide Number 7 Slide Number 8 Slide Number 9 Slide Number 10 Slide Number 11 Slide Number 12 Slide Number 13 Slide Number 14 Slide Number 15 Slide Number 16 Slide Number 17 Slide Number 18 Slide Number 19 Slide Number 20 Slide Number 21 Slide Number 22 Slide Number 23 Slide Number 24 Slide Number 25 Slide Number 26 Slide Number 27 Slide Number 28 Slide Number 29 Slide Number 30 Slide Number 31 Slide Number 32 Investor Presentation - March 2018 r4.pdf Investor Presentation - March 2018
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Colorants and Formulations_Functional Additives for IVD Devices Bulletin.pdf
Plastic materials offer opportunities and play an increasingly vital role: colors aid identification and automated laboratory processes while functional additives expand the usable property window of the polymer in areas such as surface chemistry or oxygen protection.
KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified manufacturing sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal-derived substances • Available as concentrates or ready-to-use formulations in a wide range of polymers • Functionality and color can be combined in one product for convenience REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Documentation support for approval or transition to comply with (new) regulations such as IVDR APPLICATION BULLETIN Healthcare use limitations apply—see below.
FUNCTIONALITY TARGET APPLICATIONS BLOOD COLLECTION REAGENT CONTAINERS/ KITS PIPETTE/ LABWARE SELF-TESTING/ POCT INSTRUMENT/ ACCESSORIES Colorants for coding for lab automation/ identification Wide range of colors in various polymers, available in ready-to-use formulation or concentrate adapted to your process Colors – low migration/ interference Ready-to-use formulation to avoid interference with analytical tests; extractable metal data Colors – biologically evaluated Reduced risk of non compliance to current and proposed regulations such as IVDR Color in PP, ABS, PC and high temperature polymers with UL listings Ready-to-use solutions/concentrates supporting Underwriters Laboratory requirements of electric enclosures Antistatic for PP, ABS, PC/ABS Permanent/non-migrating ready-to-use formulation; fast decay time independent of % relative humidity Clarifying PP Sorbitol-free, minimizing potential migration Laser marking for UDI replacing ink printing/labels Activation of the polymer to laser energy give high contrast solvent-free, high speed identification Laser welding for fast, reliable assembly of a range of polymers Custom concentrates and ready-to-use formulations for optically transparent and opaque colors while allowing laser transmission/absorption Nucleation of semicrystalline polymers e.g.
https://www.avient.com/products/polymer-additives/barrier-and-scavenger-additives/colormatrix-amosorb-4020l
The solution delivers full oxygen scavenging performance with up to 100% rPET content, helping customers avoid plastic tax surcharges where applicable.
https://www.avient.com/sites/default/files/AVNT February IR Presentation_w_Non-GAAP Recs.pdf
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
We also monitor earnings (defined as net income from continuing operations) before interest, taxes, depreciation and amortization (EBITDA) and adjusted EBITDA (EBITDA before the impact of special items) as a supplement to our GAAP measures.
Three Months Ended Year Ended Reconciliation of Pro Forma Adjusted Earnings per Share December 31, 2022 Net (loss) income from continuing operations attributable to Avient shareholders $ (17.0) $ 82.8 Special items, after tax 38.3 116.2 Amortization expense, after-tax 14.6 49.0 Adjusted net income from continuing operations excluding special items 35.9 248.0 Pro forma adjustments* 2.5 13.6 APM pro forma amortization expense, after-tax* — 19.1 Pro forma adjusted net income from continuing operations attributable to Avient shareholders $ 38.4 $ 280.7 Weighted average diluted shares 91.7 92.2 Pro forma adjusted EPS - excluding special items pro forma for APM acquisition $ 0.42 $ 3.04 * Pro forma adjustment to reflect APM results for the period before Avient ownership including the impacts of debt financing and paydown of debt with net proceeds from the Distribution sale. 2 Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Sales: Color, Additives and Inks $ 459.4 $ 490.8 $ 2,007.4 $ 2,355.0 Specialty Engineered Materials 259.8 300.8 1,138.2 1,044.4 Corporate (0.2) (1.2) (2.8) (2.5) Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9 Operating income: Color, Additives and Inks $ 61.8 $ 44.3 $ 259.9 $ 301.0 Specialty Engineered Materials 29.4 35.2 142.5 140.1 Corporate (48.1) (79.1) (205.6) (197.8) Operating income $ 43.1 $ 0.4 $ 196.8 $ 243.3 Other expense, net: $ 4.3 $ (28.4) $ 5.8 $ (59.7) Depreciation & amortization: Color, Additives and Inks $ 22.2 $ 25.2 $ 98.3 $ 101.3 Specialty Engineered Materials 19.8 20.3 81.5 48.7 Corporate 2.2 3.1 9.0 12.5 Depreciation & amortization $ 44.2 $ 48.6 $ 188.8 $ 162.5 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 84.0 $ 69.5 $ 358.2 $ 402.3 Specialty Engineered Materials 49.2 55.5 224.0 188.8 Corporate (45.9) (76.0) (196.6) (185.3) Other expense, net $ 4.3 $ (28.4) $ 5.8 $ (59.7) EBITDA $ 91.6 $ 20.6 $ 391.4 $ 346.1 Special items in EBITDA 22.3 86.8 110.4 162.5 EBITDA - excluding special items $ 113.9 $ 107.4 $ 501.8 $ 508.6 APM pro forma adjustments - 8 months 2022* — — — 83.1 Pro forma EBITDA $ 113.9 $ 107.4 $ 501.8 $ 591.7 * Pro forma adjustment for January - August 2022 APM results (period before Avient ownership). 3 AVNT February IR Presentation.pdf Avient corporation�investor presentation DISCLAIMER Slide Number 3 Creating a world-class�sustainable organization Top-tier sustainability performance�and recognition Slide Number 6 Slide Number 7 Portfolio transformation Slide Number 9 END MARKET observations�(% of company sales) Regional observations�(% of company sales) Slide Number 12 Slide Number 13 Slide Number 14 Slide Number 15 Slide Number 16 Slide Number 17 Slide Number 18 Slide Number 19 Slide Number 20 Slide Number 21 Slide Number 22 2023 segment, end market and Geography Color, Additives & Inks Specialty Engineered Materials Slide Number 26 AVNT Q4 2023 Earnings Presentation.pdf AVNT Q4 2023 Earnings Presentation_For Website_with Non-GAAP.pdf IR Deck - AVNT-2023.12.31 (2.12.24 9PM Milestone February 12 0905 pm).pdf Attachment
https://www.avient.com/industries/healthcare/labware-diagnostics/laboratory-equipment
Other essential features include color for specimen identification, colorable overmolds for caps and closures to maintain integrity, high clarity walls for content visibility, low retention and electrically conductive properties for increased measurement accuracy in pipettes, and custom formulations to avoid cross-talk for PCR plates.
Color and special effect masterbatches pre-tested to ISO, US Pharmacopeia, European Pharmacopeia, and ICH Q3D protocols for identification and differentiation